Bonne Bell recalls cosmetics bags
This article was originally published in The Rose Sheet
Executive Summary
The U.S. Consumer Product Safety Commission announces voluntary recall of Bonne Bell children's cosmetics accessory bags due to lead exposure risk, commission says Aug. 29. Metal clasps on bag's handle contain excessive amounts of lead and could pose risk of adverse health effects to children who play with the item, the commission says. Company notes that there have been no reports of injuries related to the bag and that cosmetics included in the bags are safe and not included in the recall. Bags from Smackers Sweet Treats, Sparkle & Shine and Glam It Up collections, as well as Bonnebell Natural Neutrals, Pretty Pinks, Fresh Pinks and Glamorous Neutrals collections, are affected, for a total of about 945,000 units. Consumers are advised to take bag away from children and contact Bonne Bell for a replacement bag. "The Bonne Bell Company solemnly regrets any inconvenience and apologizes for any concern caused by this product recall. The Company hopes that its consumers will continue to enjoy Smackers and Bonnie Bell products with confidence," firm says in statement to "The Rose Sheet.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.